Wutah dodolan YoY sajrone rolas wulan kepungkur: Matinas BioPharma (MTNB)

Logo grafis Matinas BioPharma Holdings (MTNB)

Matinas BioPharma develops innovative drug delivery systems via its LNC platform, attracting patients with severe infections to MAT2203 trials due to low toxicity. The annual sales growth rate over a 12-month period demonstrates revenue dynamics, where the value of 0.00 characterizes this level. The development strategy relies on the expansion of LNC technologies and the broadening of B2B licensing to capture the global pharmaceutical market.

Wutah dodolan YoY sajrone rolas wulan kepungkur: matinasbiopharma.com (MTNB) kanggo 11.02.2024 - 18.11.2026

Ringkesan rincian data analitis Matinas BioPharma (MTNB)

- nilai pasar lan prakiraan target analis:
- indikator kapitalisasi bursa perusahaan:
Ringkesan analitik perusahaan:MTNB (Matinas BioPharma Holdings, Inc.)
Produk seri Matinas BioPharma Holdings Inc.

Revenue dynamics for Matinas BioPharma (MTNB), which is based on proprietary drug delivery technology, are assessed by comparing total revenues over the last 12 months with the same period last year to identify expansion rates. An analysis of the trailing twelve months (TTM) growth in operating sales revenue determines whether inertial demand for the treatment of metabolic diseases is converting into sustainable financial growth without excessive costs.

Analisis pesaing Matinas BioPharma

Ascendis (ASND) - Wutah pendapatan taun lumaku|MDGL - Wutah dodolan YoY sajrone rolas wulan kepungkur|CORT: Wutah dodolan YoY sajrone rolas wulan kepungkur|RYTM: Wutah dodolan YoY (TTM)|AKRO - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur Metsera Therapeutics|MoonLake Corp (MLTX) - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur crinetics.com (CRNX)|Wutah pendapatan YoY sajrone 12 wulan kepungkur newamsterdampharma.com NAMS|Wutah dodolan YoY sajrone rolas wulan kepungkur Soleno Therapeutics Inc SLNO|Wutah dodolan YoY (TTM) Amicus Therapeutics Inc FOLD|89bio Corp - Wutah dodolan YoY (TTM)|Tingkat wutah pendapatan YoY sajrone rolas wulan kepungkur Agios Pharmaceuticals Inc (AGIO)|Structure Therapeutics (GPCR) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah pendapatan YoY sajrone 12 wulan kepungkur MiMedx Group, Inc.|Wutah dodolan YoY sajrone rolas wulan kepungkur Rezolute Bio|Lexicon Pharmaceuticals, Inc. (LXRX) - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah dodolan YoY (TTM) MBX|Wutah pendapatan YoY sajrone 12 wulan kepungkur Altimmune, Inc. ALT|Wutah dodolan YoY (TTM) AARD (Aardvark Pharma)|Sagimet Biosciences Inc. (SGMT) - Wutah pendapatan taun lumaku|BIOA: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Dinamika pendapatan YoY sajrone rolas wulan kepungkur BMEA (Biomea Fusion)|QNCX (quincetx.com) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Fractyl - Dinamika pendapatan YoY sajrone rolas wulan kepungkur|VTVT (vTv Therapeutics Inc) - Wutah dodolan YoY (TTM)|Agape ATP - Wutah dodolan taun lumaku|Wutah pendapatan YoY sajrone 12 wulan kepungkur PLUR (Pluri Inc)|Wutah pendapatan taunan sajrone rolas wulan kepungkur Synlogic Inc.|Wutah dodolan YoY sajrone rolas wulan kepungkur Lipocine Inc. LPCN|Wutah pendapatan taunan sajrone rolas wulan kepungkur Spruce Biosciences (SPRB)|GLTO: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah dodolan taun lumaku CTCX|LUMO (Lumos Pharma) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah dodolan YoY sajrone 12 wulan kepungkur ONVO|RDUS (Radius Pharmaceuticals) - Wutah dodolan YoY (TTM)